Literature DB >> 9414275

Purine nucleotides induce regulated secretion of von Willebrand factor: involvement of cytosolic Ca2+ and cyclic adenosine monophosphate-dependent signaling in endothelial exocytosis.

U M Vischer1, C B Wollheim.   

Abstract

von Willebrand factor (vWF) is stored and released from endothelial secretory granules called Weibel-Palade (WP) bodies. Acute release can be induced by thrombin, histamine, and other mediators of thrombosis or inflammation. Their effect is thought to be mediated by an increase in intracellular free calcium ([Ca2+]i). Purine nucleotides such as adenosine triphosphate (ATP) and adenosine diphosphate (ADP) are released from platelet dense granules and from ischemic tissues and are important regulators of platelet function and vascular tone. In the present study, we investigated whether they could also induce exocytosis from cultured endothelial cells. ATP (1 to 100 micromol/L) induced a dose-related increase in vWF release, with a 2.3-fold maximal increase after 30 minutes. Similar responses were observed with ADP. ATP induced calcium mobilization from intracellular stores, an effect mimicked by 2-methylthio-ATP, a selective agonist for P2y receptors. However, 2-methylthio-ATP-induced vWF release was only 43% of the ATP response. ATP-induced vWF release was also associated with a twofold increase in cellular cyclic adenosine monophosphate (cAMP) content, and was potentiated by 3-isobutyl-1-methylxanthine ([IBMX] added to increase cAMP levels by blocking cellular phosphodiesterases) and 8-bromo-cAMP and inhibited by more than 50% by Rp-8-CPT-cAMPS, a competitive protein kinase A inhibitor. Adenosine but not 2-methylthio-ATP mimicked the ATP-induced increase in cAMP. ATP-induced vWF release was partly inhibited by adenosine deaminase, which degrades adenosine generated from ATP in the incubation medium. Adenosine (1 to 100 micromol/L) failed to induce vWF release, but potentiated the secretory response to 2-methylthio-ATP and thrombin without modifying the calcium response to these agents. Our results suggest that ATP/ADP can induce vWF release from endothelial cells via dual activation of P2y and adenosine A2 receptors. ATP/ADP-induced exocytosis could be involved in the regulation of thrombus formation and ischemia-reperfusion injuries. Further, we provide evidence that a receptor-mediated increase in cellular cAMP can potentiate the secretory response to calcium-mobilizing agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9414275

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells.

Authors:  T Kobayashi; U M Vischer; C Rosnoblet; C Lebrand; M Lindsay; R G Parton; E K Kruithof; J Gruenberg
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Enzymes that hydrolyze adenine nucleotides in platelets and polymorphisms in the alpha2 gene of integrin alpha2beta1 in patients with von Willebrand disease.

Authors:  Karen Freitas Santos; Vanessa Battisti; Maísa de Carvalho Corrêa; Thaís Rapachi Mann; Renata da Silva Pereira; Maria do Carmo Araújo; Alice Odete Brülê; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
Journal:  Mol Cell Biochem       Date:  2010-03-25       Impact factor: 3.396

3.  Cav3.1 (alpha1G) controls von Willebrand factor secretion in rat pulmonary microvascular endothelial cells.

Authors:  Chun Zhou; Hairu Chen; Fengmin Lu; Hassan Sellak; Jonathan A Daigle; Mikhail F Alexeyev; Yaguang Xi; Jingfang Ju; Jan A van Mourik; Songwei Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-15       Impact factor: 5.464

Review 4.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

5.  Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39.

Authors:  Anuli C Anyanwu; Yogendra Kanthi; Keigo Fukase; Hui Liao; Tekashi Mimura; Karl C Desch; Martin Gruca; Saabir Kaskar; Hussein Sheikh-Aden; Liguo Chi; Raymond Zhao; Vinita Yadav; Thomas W Wakefield; Matthew C Hyman; David J Pinsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

6.  Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

Authors:  John H Cleator; Wen Qin Zhu; Douglas E Vaughan; Heidi E Hamm
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

7.  Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways.

Authors:  Elzbieta Kaczmarek; Laurie Erb; Katarzyna Koziak; Robert Jarzyna; Marcia R Wink; Olaf Guckelberger; J Krzysztof Blusztajn; Vickery Trinkaus-Randall; Gary A Weisman; Simon C Robson
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

8.  A Drosophila haemocyte-specific protein, hemolectin, similar to human von Willebrand factor.

Authors:  A Goto; T Kumagai; C Kumagai; J Hirose; H Narita; H Mori; T Kadowaki; K Beck; Y Kitagawa
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

9.  Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells.

Authors:  Markus Knop; Elin Aareskjold; Günther Bode; Volker Gerke
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  Cell cycle-dependent phosphorylation of human CDC5 regulates RNA processing.

Authors:  Remo Gräub; Hope Lancero; Anissa Pedersen; Meihua Chu; Krishnan Padmanabhan; Xiao-Qin Xu; Paul Spitz; Robert Chalkley; Alma L Burlingame; David Stokoe; Harold S Bernstein
Journal:  Cell Cycle       Date:  2008-06-25       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.